# WIDAPLIK
> **NDA219423** · New Drug Application · Sponsor: AZURITY · Approved 2025-06-05
## Drug
- **FDA Application Number:** NDA219423
- **Application type:** New Drug Application
- **Brand name:** WIDAPLIK
- **Generic name:** TELMISARTAN, AMLODIPINE AND INDAPAMIDE
- **Active ingredients:** AMLODIPINE BESYLATE; INDAPAMIDE; TELMISARTAN
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** AZURITY
- **Manufacturer:** Azurity Pharmaceuticals, Inc.
- **First approval:** 2025-06-05
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219423)
---
*MORVS · CC0 1.0*